Pfizer Inc
NYSE: PFE
$25.65
+$0.52 (+2.1%)
Closing Price on November 22, 2024
PFE Articles
These five top BofA Securities value stock picks come with dependable dividends, are relatively cheap and should hold up better than the overall market if the inflation-induced decline continues....
Published:
The bear market rally that started in June is over and it is clearly a time to move to safer dividend stocks. These eight outstanding health care stocks make sense for worried investors now as they...
Published:
The BofA Securities US 1 list includes the firm's 37 top stock picks. These six top companies from the list have rich dividends and are in sectors that should continue to hold their own, making them...
Published:
Bank of America has released its third-quarter list of top 10 investment ideas, which includes one short candidate.
Published:
Monday's additional analyst calls were on AbbVie, Array Technologies, Dow, DTE Energy, Gap, Pfizer, Ralph Lauren, Trimble and more.
Published:
Before markets open on Tuesday, these four companies will be releasing their first-quarter earnings reports.
Published:
A recent survey of global fund managers found that many have turned to health care for some stability in these uncertain times. These eight high-dividend-paying stocks are rated Buy at top Wall...
Published:
Given Warren Buffet's proclivity for only owning stock of companies that he understands inside and out, these 10 top health care picks with big, dependable dividends make sense now for growth and...
Published:
A few big biopharma names were on the move Tuesday morning, and analysts were taking their shot at them.
Published:
Markets closed down slightly on Monday and got off to a mixed opening Tuesday. Here's a look at the stocks that were winning and losing in the premarket trading session.
Published:
Before markets open on Tuesday, we will hear earnings results from a Dow component, an oil and gas supermajor and the country's largest food distributor.
Published:
Here's a look at how markets were shaping up for Monday's opening bell.
Published:
Wednesday afternoon's top analyst upgrades and downgrades included Adobe, Altria, Amgen, Beyond Meat, BP, Murphy Oil, Northrop Grumman, Occidental Petroleum, Peloton Interactive, Pfizer,...
Published:
Tuesday's top analyst upgrades and downgrades included Broadcom, Carrier Global, Canadian Pacific Railway, Coca-Cola, Eli Lilly, Marvell Technology, Pfizer, Regions Financial, Stryker, Synchrony...
Published:
Monday afternoon's top analyst upgrades and downgrades included Activision Blizzard, Lucid, Nokia, Pfizer, SoFi Technologies, Sunrun and Welltower.
Published: